L.T.M. Medical College & General Hospital
Welcome,         Profile    Billing    Logout  
 3 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Shah, Bela
NCT05855967: A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India

Completed
4
250
RoW
Ixekizumab, LY2439821
Eli Lilly and Company
Plaque Psoriasis, Psoriatic Arthritis
08/24
09/24
BREEZE-AD-PEDS, NCT03952559 / 2018-000349-38: A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis

Active, not recruiting
3
516
Europe, Japan, RoW
Baricitinib, LY3009104, Placebo, Topical corticosteroid
Eli Lilly and Company, Incyte Corporation
Atopic Dermatitis
04/22
05/26
ENGOT-EN20, NCT05611931 / 2022-002540-42: Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Jul 2024 - Dec 2024: Top-line data from XPORT-EC trial in participants with TP53 wild type endometrial cancer
Recruiting
3
220
Europe, Canada, US, RoW
Selinexor, KPT-330, Matching Placebo for selinexor
Karyopharm Therapeutics Inc, GOG Foundation, European Network of Gynaecological Oncological Trial Groups (ENGOT), Belgium and Luxembourg Gynaecological Oncology Group, North Eastern German Society of Gynaecological Oncology, Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies, Spanish Research Group in Ovarian Cancer, The Central and Eastern European Gynecologic Oncology Group, Israeli Society of Gynecologic Oncology, Australia New Zealand Gynaecological Oncology Group
Endometrial Cancer
01/25
01/28
ASLAN004-003, NCT05158023: Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis

Completed
2
302
Europe, Canada, US, RoW
Placebo Comparator, ASLAN004
ASLAN Pharmaceuticals
Atopic Dermatitis
06/23
09/23
NCT06646627: Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors

Recruiting
1
48
US
B7-H3CART
Crystal Mackall, MD
Ovarian Cancer
12/25
12/25
Sachdev, Mukta
NCT06278948: Efficacy and Tolerability of Test Product Versus Cysteamine 5% in Treatment of Facial Epidermal Melasma

Recruiting
N/A
140
RoW
Group TP, Test Product, Group CYS, Cysteamine 5%
Cosmetique Active International
Melasma
06/24
06/24
NCT06899321: The Effect of Cosmetic Products on Skin Brightening

Not yet recruiting
N/A
34
RoW
Cosmetic product M68, Cosmetic product Z15, Cosmetic product R52, Cosmetic product J61, Cosmetic product U36
Unilever R&D, MS Clinical Research Pvt. Ltd
Skin Brightening
05/25
05/25
Nataraja
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Shah, Bela
NCT05855967: A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India

Completed
4
250
RoW
Ixekizumab, LY2439821
Eli Lilly and Company
Plaque Psoriasis, Psoriatic Arthritis
08/24
09/24
BREEZE-AD-PEDS, NCT03952559 / 2018-000349-38: A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis

Active, not recruiting
3
516
Europe, Japan, RoW
Baricitinib, LY3009104, Placebo, Topical corticosteroid
Eli Lilly and Company, Incyte Corporation
Atopic Dermatitis
04/22
05/26
ENGOT-EN20, NCT05611931 / 2022-002540-42: Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Jul 2024 - Dec 2024: Top-line data from XPORT-EC trial in participants with TP53 wild type endometrial cancer
Recruiting
3
220
Europe, Canada, US, RoW
Selinexor, KPT-330, Matching Placebo for selinexor
Karyopharm Therapeutics Inc, GOG Foundation, European Network of Gynaecological Oncological Trial Groups (ENGOT), Belgium and Luxembourg Gynaecological Oncology Group, North Eastern German Society of Gynaecological Oncology, Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies, Spanish Research Group in Ovarian Cancer, The Central and Eastern European Gynecologic Oncology Group, Israeli Society of Gynecologic Oncology, Australia New Zealand Gynaecological Oncology Group
Endometrial Cancer
01/25
01/28
ASLAN004-003, NCT05158023: Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis

Completed
2
302
Europe, Canada, US, RoW
Placebo Comparator, ASLAN004
ASLAN Pharmaceuticals
Atopic Dermatitis
06/23
09/23
NCT06646627: Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors

Recruiting
1
48
US
B7-H3CART
Crystal Mackall, MD
Ovarian Cancer
12/25
12/25
Sachdev, Mukta
NCT06278948: Efficacy and Tolerability of Test Product Versus Cysteamine 5% in Treatment of Facial Epidermal Melasma

Recruiting
N/A
140
RoW
Group TP, Test Product, Group CYS, Cysteamine 5%
Cosmetique Active International
Melasma
06/24
06/24
NCT06899321: The Effect of Cosmetic Products on Skin Brightening

Not yet recruiting
N/A
34
RoW
Cosmetic product M68, Cosmetic product Z15, Cosmetic product R52, Cosmetic product J61, Cosmetic product U36
Unilever R&D, MS Clinical Research Pvt. Ltd
Skin Brightening
05/25
05/25
Nataraja
No trials found

Download Options